doi: 10.1161/01.RES.0000266408.42939.e4
© 2007 American Heart Association, Inc.
Reviews |
Notch Signaling in Blood Vessels
Who Is Talking to Whom About What?
From the Molecular Biology Institute (J.J.H., M.L.I.-A.), Department of Molecular, Cell and Developmental Biology (M.L.I.-A.), and The Jonsson Comprehensive Cancer Center (M.L.I.-A.), University of California, Los Angeles.
Correspondence to Dr Luisa Iruela-Arispe, Molecular Biology Institute, UCLA, 611 Charles Young Dr E, Paul Boyer Hall, Room 559, Los Angeles, CA 90095. E-mail arispe{at}mbi.ucla.edu
This Review is part of a thematic series on Transcription Factors, which includes the following articles:
Regulation of Vascular Inflammation and Remodeling by ETS Factors
Myocardin-Related Transcription Factors: Critical Coactivators Regulating Cardiovascular Development and Adaptation
Notch Signaling in Blood Vessels: Who Is Talking to Whom About What?
Role of Kruppel-Like Transcription Factors in Endothelial Biology
Forkhead Factors in Cardiovascular Biology
Mukesh Jain Guest Editor
It has become increasingly clear that the Notch signaling pathway plays a critical role in the development and homeostasis of the cardiovascular system. This notion has emerged from loss- and gain-of-function analysis and from the realization that several hereditary cardiovascular disorders originate from gene mutations that have a direct impact on Notch signaling. Current research efforts are focused on determining the specific cellular and molecular effects of Notch signaling. The rationale for this has stemmed from the clinical importance and therapeutic potential of modulating vascular formation during various disease states. A more complete appreciation of Notch signaling, as it relates to vascular morphogenesis, requires an in-depth knowledge of expression patterns of the various signaling components and a comprehensive understanding of downstream targets. The goal of this review is to summarize current knowledge regarding Notch signaling during vascular development and within the adult vascular wall. Our focus is on the genetic analysis and cellular experiments that have been performed with Notch ligands, receptors, and downstream targets. We also highlight questions and controversies regarding the contribution of this pathway to vascular development.
Key Words: Alagille syndrome • CADASIL • endothelium • smooth muscle • vascular development
This article has been cited by other articles:
 |
|
 |
|
  D. A. Venkatesh, K.-S. Park, A. Harrington, L. Miceli-Libby, J. K. Yoon, and L. Liaw Cardiovascular and Hematopoietic Defects Associated With Notch1 Activation in Embryonic Tie2-Expressing Populations Circ. Res., August 15, 2008; 103(4): 423 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Niessen and A. Karsan Notch Signaling in Cardiac Development Circ. Res., May 23, 2008; 102(10): 1169 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. le Noble, C. Klein, A. Tintu, A. Pries, and I. Buschmann Neural guidance molecules, tip cells, and mechanical factors in vascular development Cardiovasc Res, May 1, 2008; 78(2): 232 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tang, S. Urs, and L. Liaw Hairy-Related Transcription Factors Inhibit Notch-Induced Smooth Muscle {alpha}-Actin Expression by Interfering With Notch Intracellular Domain/CBF-1 Complex Interaction With the CBF-1-Binding Site Circ. Res., March 28, 2008; 102(6): 661 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Arboleda-Velasquez, Z. Zhou, H. K. Shin, A. Louvi, H.-H. Kim, S. I. Savitz, J. K. Liao, S. Salomone, C. Ayata, M. A. Moskowitz, et al. Linking Notch signaling to ischemic stroke PNAS, March 25, 2008; 105(12): 4856 - 4861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aikawa The Balance of Power: The Law of Yin and Yang in Smooth Muscle Cell Fate: Is YY1 a Vascular Protector? Circ. Res., July 20, 2007; 101(2): 111 - 113. [Full Text] [PDF]
|
|